Catalyst Pharmaceuticals (CPRX) FCF Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -259.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -259.00 |
| Dec 31, 2025 | -2,052.00 |
| Sep 30, 2025 | -3,456.00 |
| Jun 30, 2025 | -363.00 |
| Mar 31, 2025 | 1,025.00 |
| Dec 31, 2024 | -33.00 |
| Sep 30, 2024 | 1,254.00 |
| Jun 30, 2024 | 2,137.00 |
| Mar 31, 2024 | 1,815.00 |
| Dec 31, 2023 | -1,572.00 |
| Sep 30, 2023 | -2,826.00 |
| Jun 30, 2023 | -1,843.00 |
| Mar 31, 2023 | -562.00 |
| Dec 31, 2022 | 1,601.00 |
| Sep 30, 2022 | 1,196.00 |
| Jun 30, 2022 | 621.00 |
| Mar 31, 2022 | 1,006.00 |
| Dec 31, 2021 | 770.00 |
| Sep 30, 2021 | 2,113.00 |
| Jun 30, 2021 | -170.00 |
| Mar 31, 2021 | -1,514.00 |
| Dec 31, 2020 | 145.00 |
| Sep 30, 2020 | -1,357.00 |
| Jun 30, 2020 | -395.00 |
| Mar 31, 2020 | 8,920.00 |
| Dec 31, 2019 | 172,249.00 |